ADAP - Adaptimmune EPS beats by $0.19 beats on revenue November, 05 2020 07:36 AM Adaptimmune Therapeutics plc Adaptimmune (ADAP): Q3 GAAP EPS of -$0.04 beats by $0.19.Revenue of $1.19M (+395.8% Y/Y) beats by $0.17M.Press Release For further details see: Adaptimmune EPS beats by $0.19, beats on revenue